"User-friendly" Levodopa, Advancing Treatment, and Teaching Parkinson's Disease


Norika Malhado-Chang, MD, assistant professor of Neurology at University of California at Davis, discusses how progress in Parkinson's disease and movement disorders is changing the scope of comprehensive care, addressing non-motor symptoms, and supplying tools for the next generation of neurology specialists.

Norika Malhado-Chang, MD, teaches clinical neurology for 3rd- and 4th-year medical students at the University of California at Davis. That responsibility on the assistant professor of Neurology compounds when one considers the great changes of perspective, product, and procedure that have come into the fields of Parkinson's diseas and movement disorders as of late.

At the 21st International Congress of Parkinson's Disease and Movement Disorders in Vancouver, BC, Malhado-Chang discussed advocacy for comprehensive care, improving the safety and efficacy of treatment staple levodopa, and helping shape the future generation of Parkinson's disease specialists.

Related Videos
Therapies in Development for Hidradenitis Suppurativa
"Prednisone without Side Effects": The JAK Inhibitor Ceiling in Dermatology
Ghada Bourjeily, MD: Research Gaps on Sleep Issues During Pregnancy
John Winkelman, MD, PhD: When to Use Low-Dose Opioids for Restless Legs Syndrome
Bhanu Prakash Kolla, MBBS, MD: Treating Sleep with Psychiatric Illness
How Will Upadacitinib, Povorcitinib Benefit Hidradenitis Suppurativa?
Jennifer Martin, PhD: Boosting CPAP Adherence in Women with Sleep Apnea
© 2024 MJH Life Sciences

All rights reserved.